LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Rapid regression of microsatellite instability-high/programmed cell death ligand 1-negative recurrent endometrial carcinoma by immune checkpoint blockade with pembrolizumab: A case report and literature review

Photo by charlesdeluvio from unsplash

Highlights • Effective treatment options for recurrent endometrial carcinomas are limited.• Immune checkpoint inhibitor is a recent progress in cancer immunotherapy.• Reports on recurrent endometrial carcinomas managed by pembrolizumab are… Click to show full abstract

Highlights • Effective treatment options for recurrent endometrial carcinomas are limited.• Immune checkpoint inhibitor is a recent progress in cancer immunotherapy.• Reports on recurrent endometrial carcinomas managed by pembrolizumab are limited.

Keywords: immune checkpoint; regression microsatellite; recurrent endometrial; pembrolizumab; rapid regression

Journal Title: Gynecologic Oncology Reports
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.